Literature DB >> 15145053

Cloning and characterisation of the RBCC728/TRIM36 zinc-binding protein from the tumor suppressor gene region at chromosome 5q22.3.

Ildiko Balint1, Anke Müller, Anetta Nagy, Gyula Kovacs.   

Abstract

DNA alterations at chromosome 5q22 occur frequently in different types of tumors including urological cancers. Previously, we narrowed a common target region between loci D5S659 and D5S2055 at chromosome 5q22.3 by microsatellite allelotyping. After constructing a BAC contig and shot-gun sequencing we identified a putative exon by the NIX software package. By PCR cloning using the putative exon (5qex5) specific primers and primers directed to the vector (lambdaZAPII) sequence of human brain and kidney cDNA libraries, we obtained a full-length cDNA of 4074 bp of the new gene RBCC728/TRIM36 (GenBank accession no.) with an ORF coding for a protein of 728 amino acids. The TRIM36, which is a new member of the tripartite motif (TRIM) gene family, shows a RING finger C3HC4 structure, two B-box, a coiled-coil, a fibronectin type III and a C-terminal domain of unknown function (SPRY). The TRIM36 has a weak homology to MID1. Immunohistochemistry of recombinant and native TRIM36 displays a cytoplasmic, slightly filamentous staining pattern in COS-7 cells. The TRIM36 is expressed in adult testis, brain, prostate, kidney, heart and lung. A variable level of TRIM36 expression was detected by Q-RT-PCR in conventional RCC, while the gene was consequently upregulated in PCs. We did not find mutation in the open reading frame of the TRIM36 in cancer cells. The overexpression of the TRIM36 in the vast majority of prostate cancer suggest that this gene might be involved in the prostate tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145053     DOI: 10.1016/j.gene.2004.02.045

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.913


  12 in total

1.  The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD.

Authors:  Mikael Lerner; Martin Corcoran; Diana Cepeda; Michael L Nielsen; Roman Zubarev; Fredrik Pontén; Mathias Uhlén; Sophia Hober; Dan Grandér; Olle Sangfelt
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

2.  Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy.

Authors:  Yan Shou; Zhijun Ma; Taihe Lu; Brian P Sorrentino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

3.  The Expression of Tripartite Motif Protein 36 and β-Catenin Correlates with the Prognosis of Esophageal Cancer.

Authors:  Hua Zhang; Wenlong Sun; Gaofeng Qiao; Bin Zhao; Xiangyan Liu; Feng Zhu
Journal:  Gastroenterol Res Pract       Date:  2020-07-31       Impact factor: 2.260

4.  TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies.

Authors:  Kunikazu Tanji; Tetsu Kamitani; Fumiaki Mori; Akiyoshi Kakita; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Neurobiol Dis       Date:  2010-01-18       Impact factor: 5.996

5.  Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.

Authors:  Emmanouil Papasavvas; Andrew V Kossenkov; Livio Azzoni; Nicola M Zetola; Agnieszka Mackiewicz; Brian N Ross; Matthew Fair; Surya Vadrevu; Doreen Ramogola-Masire; Ian Sanne; Cynthia Firnhaber; Luis J Montaner
Journal:  Carcinogenesis       Date:  2019-04-29       Impact factor: 4.944

6.  Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.

Authors:  Lincoln D Nadauld; Sarah Garcia; Georges Natsoulis; John M Bell; Laura Miotke; Erik S Hopmans; Hua Xu; Reetesh K Pai; Curt Palm; John F Regan; Hao Chen; Patrick Flaherty; Akifumi Ootani; Nancy R Zhang; James M Ford; Calvin J Kuo; Hanlee P Ji
Journal:  Genome Biol       Date:  2014-08-27       Impact factor: 17.906

7.  TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.

Authors:  Chao Liang; Shangqian Wang; Chao Qin; Meilin Bao; Gong Cheng; Bianjiang Liu; Pengfei Shao; Qiang Lv; Ninghong Song; Lixin Hua; Min Gu; Jie Li; Zengjun Wang
Journal:  Cell Death Dis       Date:  2018-02-05       Impact factor: 9.685

8.  Androgen-responsive tripartite motif 36 enhances tumor-suppressive effect by regulating apoptosis-related pathway in prostate cancer.

Authors:  Naoki Kimura; Yuta Yamada; Ken-Ichi Takayama; Tetsuya Fujimura; Satoru Takahashi; Haruki Kume; Satoshi Inoue
Journal:  Cancer Sci       Date:  2018-10-30       Impact factor: 6.518

9.  TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.

Authors:  Weihua Zhan; Tianyu Han; Chenfu Zhang; Caifeng Xie; Mingxi Gan; Keyu Deng; Mingui Fu; Jian-Bin Wang
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

10.  TRIM proteins in neuroblastoma.

Authors:  Yonghu Xu; Zihan Zhang; Guofeng Xu
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.